4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-294863
Chief Financial Officer acquired 1,541 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fenton Mary Kay · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-30 | Grant or award : show line 1 in the form | +1,541 | $8.60 | $13,253 | 127,921 | D |
Loading xslF345X06/ownership.xml…